or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    RAPT F RAPT Therapeutics, Inc. -0.64
    FNCH F Finch Therapeutics Group, Inc. 57.48
    BHC F Bausch Health Companies Inc. 1.16
    CUE F Cue Biopharma, Inc. -7.17
    PRTC F PureTech Health plc -2.42
    BIIB F Biogen Idec Inc. -1.17
    OTLK F Outlook Therapeutics, Inc. -4.52
    CVS C CVS Caremark Corporation -0.50
    TAK C Takeda Pharmaceutical Company Limited -0.22
    ORIC C Oric Pharmaceuticals, Inc. -5.27
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Cancer Immunology Medicine Pharmacy Monoclonal Antibody Alzheimer's Disease Autoimmune Disorders Cancer Treatment Clinical Medicine Colitis Diarrhea Disease Gastroenterology Gastrointestinal Immune Disorders Medication Monoclonal Antibodies

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    PPH A Market Vectors Pharmaceutical ETF 4.56
    IWC B iShares Microcap ETF 2.0
    FLCO A Franklin Liberty Investment Grade Corporate ETF 1.02
    IWM B iShares Russell 2000 ETF 1.0
    ITOT B iShares Core S&P Total U.S. Stock Market ETF 1.0
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare FLCO to IWM Compare IWC to FLCO Compare PPH to IWC

        Specialty Drugs Stocks Recent News

        Date Stock Title
        Aug 1 BIIB Biogen (BIIB) Q2 2024 Earnings Call Transcript
        Aug 1 BIIB Biogen Inc. (BIIB) Q2 2024 Earnings Call Transcript
        Aug 1 BIIB Biotech Stock Roundup: BMY, GSK, BIIB's Q2 Results, VTVT Down on Setback
        Aug 1 BIIB Biogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
        Aug 1 BHC Bausch Health Companies (BHC) Q2 2024 Earnings Call Transcript
        Aug 1 BIIB Sage Therapeutics (SAGE) Q2 Loss Wider Than Expected, Sales Rise
        Aug 1 BIIB Biogen Q2 Earnings: Beats Consensus, Lifts 2024 Profit Forecast As New Drug Launches Expected To Offset Decline In Multiple Sclerosis Med Sales
        Aug 1 BIIB Biogen Stock Slips As Alzheimer's Drug Looks Abroad For Quarterly Beat
        Aug 1 BHC Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
        Aug 1 BIIB Biogen Lifts Earnings Guidance After Revenue Beats Forecasts
        Aug 1 BIIB Biogen (BIIB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
        Aug 1 BIIB Biogen posts Q2 beat as sales from Alzheimer’s drug pick up
        Aug 1 BIIB Biogen Inc. 2024 Q2 - Results - Earnings Call Presentation
        Aug 1 BHC Bausch Health (BHC) Beats Q2 Earnings and Revenue Estimates
        Aug 1 BHC Bausch Health Companies Inc. 2024 Q2 - Results - Earnings Call Presentation
        Aug 1 BHC Bausch Health Companies reports Q2 results
        Aug 1 BIIB Biogen Inc. (BIIB) Q2 Earnings and Revenues Top Estimates
        Aug 1 BIIB Meta Platforms, Ferrari, ConocoPhillips rise premarket; Arm, Moderna fall
        Aug 1 CVS CVS Health launches first-of-its-kind initiative to support patients most vulnerable to health impacts of extreme weather events
        Aug 1 BIIB Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biopharmaceutical Biotechnology Life Sciences Immunology Cancer Monoclonal Antibody Pharmacy Alzheimer's Disease Arcturus Therapeutics Biology Biomarker Technology Biomarkers Cancer Center Cancer Treatment Central Nervous System Disorders Choline Chronic Disease Clinical Medicine Cognitive Dysfunction Dementia
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags